Ascentage Pharma Group International (AAPG) Assets Average (2025)
Ascentage Pharma Group International posted quarterly Assets Average of $1.4 billion for Q4 2025.
Ascentage Pharma Group International (AAPG) has 1 years of Assets Average data on file, last reported at $1.4 billion in Q4 2025.
- For the quarter ending Q4 2025, Assets Average changed N/A year-over-year to $1.4 billion; the trailing twelve-month figure through Dec 2025 stood at $1.4 billion (changed N/A YoY), and the FY2025 full-year result was $458.0 million, up 28.7% from the prior year.
- Assets Average for Q4 2025 stood at $1.4 billion.
- Across five years, Assets Average topped out at $1.4 billion in Q4 2025 and bottomed at $1.4 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 40.71 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | 26.03 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Ascentage Pharma Group International | 1.11 Bn | 937.28 Mn | - | 1.41 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.41 Bn |